How many 8-K filings has Atea Pharmaceuticals, Inc. filed?

Atea Pharmaceuticals, Inc. (AVIR) has 13 8-K (Current Event Report) filings on record, spanning Feb 2024 to Aug 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Atea Pharmaceuticals, Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Atea Pharmaceuticals, Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Atea Pharmaceuticals, Inc. (AVIR) — 8-K Filings

All 8-K filings from Atea Pharmaceuticals, Inc.. Browse 13 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (13)

Atea Pharmaceuticals Files 8-K on Financials — Aug 7, 2025 Risk: low
On August 7, 2025, Atea Pharmaceuticals, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as
Atea Pharmaceuticals Files 8-K for Shareholder Vote Matters — Jun 20, 2025 Risk: low
On June 20, 2025, Atea Pharmaceuticals, Inc. filed an 8-K report to announce the submission of matters to a vote of its security holders. The filing does not di
Atea Pharmaceuticals Files 8-K on Financials — May 12, 2025 Risk: low
Atea Pharmaceuticals, Inc. filed an 8-K on May 12, 2025, reporting on its results of operations and financial condition, as well as financial statements and exh
Atea Pharmaceuticals Files 8-K with Key Corporate Updates — Apr 17, 2025 Risk: medium
Atea Pharmaceuticals, Inc. filed an 8-K on April 17, 2025, reporting on April 16, 2025. The filing indicates an entry into a material definitive agreement, resu
Atea Pharmaceuticals Files 8-K for Financials — Mar 24, 2025 Risk: low
Atea Pharmaceuticals, Inc. filed an 8-K on March 24, 2025, reporting events that occurred on March 21, 2025. The filing primarily concerns financial statements
Atea Pharmaceuticals Files 8-K on Financials — Mar 6, 2025 Risk: low
Atea Pharmaceuticals, Inc. filed an 8-K on March 6, 2025, to report on its results of operations and financial condition, as well as to file financial statement
Atea Pharmaceuticals Announces Board and Executive Changes — Feb 24, 2025 Risk: medium
Atea Pharmaceuticals, Inc. announced on February 20, 2025, changes in its board of directors and executive compensation arrangements. Specifically, the company
Atea Pharmaceuticals Files 8-K on Financials — Jan 14, 2025 Risk: low
Atea Pharmaceuticals, Inc. filed an 8-K on January 14, 2025, reporting on events as of January 13, 2025. The filing pertains to the company's results of operati
Atea Pharmaceuticals Files 8-K on Financials — Nov 7, 2024 Risk: low
Atea Pharmaceuticals, Inc. filed an 8-K on November 7, 2024, reporting on its results of operations and financial condition, as well as filing financial stateme
Atea Pharmaceuticals Files 8-K on Financials — Aug 7, 2024 Risk: low
Atea Pharmaceuticals, Inc. filed an 8-K on August 7, 2024, reporting on its results of operations and financial condition. The filing includes financial stateme
Atea Pharmaceuticals Holds Annual Meeting, Elects Directors — Jun 21, 2024 Risk: low
On June 21, 2024, Atea Pharmaceuticals, Inc. filed an 8-K report to announce the results of its 2024 Annual Meeting of Stockholders. The company reported that a
Atea Pharmaceuticals Files 8-K on Financials — May 14, 2024 Risk: medium
Atea Pharmaceuticals, Inc. filed an 8-K on May 14, 2024, reporting on its results of operations and financial condition, as well as financial statements and exh
Atea Pharma Files 8-K on Financial Condition and Operations — Feb 28, 2024 Risk: low
Atea Pharmaceuticals, Inc. filed an 8-K on February 28, 2024, to report on its results of operations and financial condition. The filing, under SEC File Number

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX